Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells

Cited by (120)

Items 101–120 of 120

1. Strategies in secondary biliary fibrosis
   José Manuel Hermosillo‐Sandoval, Adolfo Daniel Rodríguez-Carrizález, Alejandra Guillermina Miranda‐Díaz · 2013 · Journal of Biomedical Science and Engineering
2. The Histological Structure of the Liver after the Administration of Interferon Α -2a in Adult Male Albino Rats and the Role of Ursodeoxycholic Acid (UDCA) Supplementation
   Amal A. Afeefy · 2015
3. Future Therapies for Primary Sclerosing Cholangitis
   Craig Steven Lammert, Raj Vuppalanchi · 2016 · Springer eBooks
4. Emerging therapeutic targets for primary sclerosing cholangitis
   Amir Kalani, James H. Tabibian, Keith D. Lindor · 2018 · Expert Opinion on Orphan Drugs
5. The protective effects of ursodeoxycholic acid and the selective cyclooxygenase-2 inhibitor celecoxib on liver damage in an experimental cholestasis model
   Adem Kucuk, Hülya Öztürk · 2019 · Experimental Biomedical Research
6. Albumin inhibits the activation of hepatic stellate cells by suppressing TGF-β/Smad3 signaling via IL-1β
   Ji Hoon Park, Jang‐Hyun Kim, So-Young Choi, Kiweon Cha, Heekyung Park, Jung Eun Lee, Boram Lee, Ji Wook Moon, Sun-Hwa Park, Jae Min Lee et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
7. Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis
   Jessica Leighton, David E. Jones, Jessica Katharine Dyson, Heather Jane Cordell · 2024 · BMC Medical Genomics
8. 自己免疫性肝炎による門脈圧亢進症症例に all-trans-retinoic acid が有効であった急性前骨髄球性白血病
   牛木隆志, 公司 新國, 千絵 吉田, 柴崎 康彦, 石川 達, 増子 正義, 高井 和江 · 2012 · 臨床血液
9. Additional file 2 of Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis
   Jessica Leighton, Jones, David E. J., Jessica Katharine Dyson, Cordell, Heather J. · 2024 · Figshare
10. Additional file 1 of RETRACTED ARTICLE: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats
    Liu, Cheng, Yang, Zongguo, Wang, Lei, Lu, Yunfei, Bozong Tang, Miao, Hui, Xu, Qingnian, Xiaorong Chen · 2015 · Figshare
11. Additional file 3 of Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis
    Jessica Leighton, Jones, David E. J., Jessica Katharine Dyson, Cordell, Heather J. · 2024 · Figshare
12. Additional file 1 of Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis
    Jessica Leighton, Jones, David E. J., Jessica Katharine Dyson, Cordell, Heather J. · 2024 · Figshare
13. Nomogram Using Taurocholic Acid, Age, and Albumin to Predict HBV-Related Cirrhosis/HCC in CHB Patients
    Xuemei Zhang, Liming Zheng, Wenlan Zheng, Jia Shi, Shihan Yu, Hao Liu, Hai Feng, Zhuo Yu · 2026 · Journal of Hepatocellular Carcinoma
14. Design, Synthesis, and Mechanistic Evaluation of l -Theanine Derivatives Targeting Cathepsin D for Anti-Hepatic Fibrosis
    Miao Lv, Simin Guo, Congying Huang, Zhenning Lu, Yiming Li, Yang Li, Yichen Liu, Hongwei He, Yang Hexian, Zhang Nz et al. · 2026 · Journal of Medicinal Chemistry
15. Efficiency of all-trans retinoic acid in liver cancer
    Abdolamir Allameh, Marco Cordani, Reyhaneh Niayesh‐Mehr, Mina Allameh, Sahel Sarabandi · 2026 · Elsevier eBooks
16. Étude du rôle de PRDM16 dans l'activation des cellules hépatiques stellaires
    Pierre Mesdom · 2017
17. Rôle du récepteur purinergique P2X4 dans l'activation des myofibroblastes au cours de la fibrogenèse hépatique
    Camille Le Guilcher · 2018 · theses.fr (ABES)
18. Sitagliptin protects against bile duct ligation-induced cholemic nephropathy in male rats through modulation of inflammation, sestrin2, and the Nrf2/SOD pathway
    Mohammad Reza Akhbari, Shadan Saberi, Mohammad Khaksari, Majid Askaripour, Elham Jafari · 2026 · Research in Pharmaceutical Sciences
19. Possibilities for Cytoprotective Liver Therapy, Stable Gastric Pentadecapeptide BPC 157, and Standard Agents—A Narrative Review
    M. Sever, A. Zenko Sever, R. Klicek, L. Kralj, M. P. Dolic, Krešimir Luetić, Dinko Bekić, Željka Belošić-Halle, Mario Sučić, S. Sikirić et al. · 2026 · Pharmaceuticals
20. BindingDB Entry 50023595: Identification of Novel Cyclobutane-Based Derivatives as Potent Acetyl-CoA Carboxylase Allosteric Inhibitors for Nonalcoholic Steatohepatitis Drug Discovery.
    BindingDB · 2026 · UC San Diego